Full text is available at the source.
Abstract
A CRISPR-Cas12a-based detection system for monkeypox virus can achieve a detection limit as low as 10 aM.
- The system specifically targets the MPXV A27L gene and shows no cross-reactivity with other orthopoxviruses.
- Results can be obtained in under 40 minutes, making it suitable for rapid testing.
- Validation using six different clinical sample types indicates that herpes fluid and saliva are the most effective for detection.
- Findings align with results from qPCR, suggesting comparable reliability.
- Lyophilization of RPA and CRISPR reagents enhances transport, storage, and deployment capabilities.
Simplified